Accelr8 Technology Corp.

News & Analysis

accelr8 technology corp. - All News and Analysis

• Accelr8 Technology Corp. to Resume Trading On Nasdaq and Shareholder Class Action to Continue, Announces Berman, DeValerio & Pease, LLP

  - 2000-06-26

  Business Editors and Legal Writers DENVER--BUSINESS WIRE--June 26, 2000 Berman, DeValerio & Pease LLP a law firm specializing in representing shareholders in class action lawsuits, issues the following press release: Accelr8 Technology Corporation ("Accelr8" or the "Company") (NASDAQ: ACLY) is resumed trading on...

  Tags: Accelr8 Technology Corp., Company, FINANCE, Nasdaq Stock Market Inc., shareholder, Y2K

• Spector, Roseman, & Kodroff, P.C. Announces Class Periods for Securities Class Action Lawsuits Against Accelr8 Technology Corp., Citrix Systems, Inc., S1 Corp., PE Corp. Celera Genomics Group, Cyber-Care, Inc., First Security Corp., Flooring America,

  - 2000-06-22

  Business Editors/Legal Writers PHILADELPHIA--BUSINESS WIRE--June 22, 2000 SPECTOR, ROSEMAN, & KODROFF has filed Class Action lawsuits against or asked to investigate the following companies at the request of shareholders who purchased securities during the Class Periods stated below. Investors who purchased any of the following securities during the...

  Tags: Accelr8 Technology Corp., Citrix Systems Inc., Company, FINANCE, financial, Investment, lawsuit, Nasdaq Stock Market Inc., S1 Corp., stock

• Year 2000 Wire/Accelr8 Technology Wins Year 2000 Ford Motor Company Account

  - 1997-09-22

  DENVER--BUSINESS WIRE--Sept. 22, 1997--Accelr8 Technology Corporation (NASDAQ: ACLY) announced today a worldwide licensing agreement with Ford Motor Company of Dearborn, Michigan for Navig8 2000; Accelr8's software solution for Year 2000 compliance within Unix environments and Digital Equipment Corporation VAX and Alpha VMS systems. Under terms of the...

  Tags: Accelr8 Technology Corp., Digital Equipment Corp., environment, Ford Motor Co., SOFTWARE, UNIX, Y2K

Additional Resources

• Accelr8 Presents Data on Rapid Identification of New KPC 'Superbug'

  - 2009-05-31

  Wireless News05-31-2009Accelr8 Presents Data on Rapid Identification of New KPC 'Superbug'Type: NewsAccelr8 Technology Corp. presented new data at the 109th General Meeting of the American Society for Microbiology ASM in Philadelphia. In a release, the company noted that Company scientists and their collaborators from the Washington University in St....

• Accelr8 Presents Data on Rapid Identification of New KPC “Superbug” and Other Multi-Resistant Pathogens

  - 2009-05-28

  DENVER -- Accelr8 Technology Corporation (NYSE Amex: AXK) presented new data at the 109 th General Meeting of the American Society for Microbiology ASM in Philadelphia. Company scientists...

• Accelr8 Announces Extension by NYSE and Acceptance of the Company’s Plan to Regain Compliance for Continued Listing on the NYSE Alternext US

  - 2009-03-19

  DENVER -- Accelr8 Technology Corporation (NYSE Alternext US: AXK) (the “Company”) announced today that on March 18, 2009 it received a notice from the staff (the “Exchange Staff”)...

• Accelr8 Announces Collaboration with Denver Health Medical Center in Study of ICU Patients

  - 2009-02-12

  DENVER -- Accelr8 Technology Corporation (Alternext: AXK) today announced that the company will collaborate with the Denver Health Medical Center DHMC in a study of ICU patients at risk for contracting ventilator-associated pneumonia VAP. Denver Health is receiving funding for the study as a Team Science Award from the Colorado...

• Accelr8 Announces Study Results with Rapid ESBL Test for Broad Resistance in Gram-Negative Pathogens

  - 2008-11-06

  DENVER -- Accelr8 Technology Corporation (Amex: AXK) announced study results today that were presented at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, www.icaac.org) and the Infectious Diseases Society of America (IDSA, www.idsociety.org), October 25-29 in Washington, DC. The purpose of the study...

• Accelr8 Announces Study Results Projecting the Impact of Rapid Diagnosis on Choice of Initial Therapy in Serious Infections

  - 2008-11-04

  DENVER -- Accelr8 Technology Corporation (Amex: AXK) announced today that research investigators at the Denver Health Medical Center presented results of a study using the company's BACcel[TM] rapid diagnostic system. They presented results of a retrospective study at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents...

• Accelr8 Announces Publication of New Study on its OptiChem® High-Performance Bio-Coatings

  - 2008-09-11

  Bio-Coatings Now Available for Co-Development and Licensing DENVER -- Accelr8 Technology Corporation (Amex: AXK) announced today that two teams of university research collaborators report new methods for scalable production with the company's patented OptiChem[R] bio-coatings. Led by Dr. David Grainger at the University of Utah, researchers from the...